DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections

Influenza virus remains a significant public health threat despite innovative vaccines and antiviral drugs. A major limitation to current vaccinations and therapies against influenza virus is pathogenic diversity generated by shift and drift. A simple, cost-effective passive immunization strategy vi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Vaccines
Main Authors: Elliott, Sarah T. C., Kallewaard, Nicole L., Benjamin, Ebony, Wachter-Rosati, Leslie, McAuliffe, Josephine M., Patel, Ami, Smith, Trevor R. F., Schultheis, Katherine, Park, Daniel H., Flingai, Seleeke, Wise, Megan C., Mendoza, Janess, Ramos, Stephanie, Broderick, Kate E., Yan, Jian, Humeau, Laurent M., Sardesai, Niranjan Y., Muthumani, Kar, Zhu, Qing, Weiner, David B.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627301/
https://ncbi.nlm.nih.gov/pubmed/29263874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-017-0020-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados